Blanket Purchase Agreement V797D40222-36C24922A0008
Award Date
4/1/22
Last Date to Order
3/31/24
Federal Agency
Veterans Integrated Service Network 9
Awardee
Abbott Molecular Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
Abbott Molecular Inc. was awarded a single-award Blanket Purchase Agreement under GSA Schedule FSS-65-VII for invitro diagnostics, reagents, and tests by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9. The BPA has a potential value of $1,715,196.45 to provide reagents and consumables for the period of April 1, 2024 through March 31, 2029. A sole source task order was issued against this BPA for the base year with an award date of April...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) contract to Abbott Molecular Inc., a subsidiary of the global healthcare company Abbott Laboratories. The $12.5 million, 5-year BPA provides the VA with Alinity-M reagent kits, consumables, and related molecular diagnostics equipment and services. The contract does not utilize any set-aside designations, reflecting Abbott Molecular's status as a large, established medical technology provider. Under this BPA,...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Abbott Molecular Inc., a subsidiary of the global healthcare company Abbott Laboratories. The 5-year, $12.5 million BPA contract provides ALINITY M REAGENTS, which are molecular diagnostic supplies and equipment used to support healthcare services for veterans. The VA has issued multiple call orders under this BPA, with the most recent being a $1.48...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide Alinity reagents, controls, and consumables. The BPA has a ceiling value of $3,814,912.30 and a performance period through April 30, 2029. As a leading provider of molecular diagnostic products and services to federal government customers, Abbott Molecular has supplied a range of equipment, reagents, and testing capabilities to...
Abbott Molecular Inc., a subsidiary of Abbott Laboratories, has been awarded multiple Federal Supply Schedule (FSS) contracts and Blanket Purchase Agreements (BPAs) by the Department of Veterans Affairs (VA) Veterans Health Administration to provide in vitro diagnostic products, reagents, and services. The contracts, valued up to $11.4 million, utilize the Invitro Diagnostics, Reagents, Test (FSS-65-VII) GSA Schedule and typically involve firm fixed price delivery orders for items such as...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 awarded a $10.8 million Blanket Purchase Agreement (BPA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the provision of ALINITY M COVID-19 testing, HIV testing, and HPV testing supplies. The contract has a period of performance through September 21, 2026 and was not set aside for any specific business type. Under this BPA, the VA has awarded multiple firm fixed-price task orders to Abbott Molecular...
The Department of Veterans Affairs Veterans Integrated Service Network 2 (VA-VISN 2) awarded a Blanket Purchase Agreement (BPA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide nucleic acid and SARS testing services. The BPA, valued at up to $1.3 million, is based on Abbott Molecular's Federal Supply Schedule 66-III contract for Critical Analyzers, Laboratory products and services. Under this single-award IDV, Abbott Molecular will deliver real-time PCR testing...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide COVID-19 testing equipment, molecular analyzers, and reagents. The BPA, which has a total ceiling value of $6,325,044.25, utilizes the GSA Schedule 65-VII contract for in vitro diagnostics, reagents, and tests. Under the BPA, the VA has issued multiple firm-fixed price delivery orders with...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a Blanket Purchase Agreement to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, against the parent company's Federal Supply Schedule contract for critical analyzers and laboratory supplies. The BPA has a potential value of $9,134,282.40 to be spent through January 14, 2024 and aims to procure Abbott Laboratories medical supplies to support VHA programs. Two task orders...
This federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The BPA, valued up to $3.2 million, is for the provision of Alinity M reagents and supplies, including COVID-19 testing reagents, to support the VA's medical diagnostic operations. The contract does not utilize any set-aside designations, as Abbott Molecular is a large business. The BPA...